Julie R Beegle
Overview
Explore the profile of Julie R Beegle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderson J, Lodigiani A, Barbaduomo C, Beegle J
J Gene Med
. 2024 Jul;
26(7):e3717.
PMID: 38967915
Background: Synaptic Ras GTPase activating protein 1 (SYNGAP1)-related non-specific intellectual disability is a neurodevelopmental disorder caused by an insufficient level of SynGAP1 resulting in a dysfunction of neuronal synapses and...
2.
Harding A, Cortez-Toledo E, Magner N, Beegle J, Coleal-Bergum D, Hao D, et al.
Stem Cells
. 2017 Mar;
35(4):909-919.
PMID: 28248004
Pluripotent stem cells are a promising source of endothelial cells (ECs) for the treatment of vascular diseases. We have developed a robust protocol to differentiate human induced pluripotent stem cells...
3.
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
Beegle J, Magner N, Kalomoiris S, Harding A, Zhou P, Nacey C, et al.
Mol Ther Methods Clin Dev
. 2016 Sep;
3:16053.
PMID: 27610394
Numerous clinical trials are utilizing mesenchymal stem cells (MSC) to treat critical limb ischemia, primarily for their ability to secrete signals that promote revascularization. These cells have demonstrated clinical safety,...
4.
Fierro F, ONeal A, Beegle J, Chavez M, Peavy T, Isseroff R, et al.
Front Cell Dev Biol
. 2015 Nov;
3:68.
PMID: 26579521
Many therapies using mesenchymal stem cells (MSC) rely on their ability to produce and release paracrine signals with chemotactic and pro-angiogenic activity. These characteristics, however, are mostly studied under standard...
5.
Hu X, Caskey C, Mahakian L, Kruse D, Beegle J, Decleves A, et al.
Am J Nucl Med Mol Imaging
. 2013 Aug;
3(4):336-49.
PMID: 23901359
Ultrasound can selectively and specifically visualize upregulated vascular receptors through the detection of bound microbubbles. However, most current ultrasound molecular imaging methods incur delays that result in longer acquisition times...
6.
Hu X, Kheirolomoom A, Mahakian L, Beegle J, Kruse D, Lam K, et al.
Invest Radiol
. 2012 Jun;
47(7):398-405.
PMID: 22659591
Objectives: In ultrasound molecular imaging, a sequence of high-pressure ultrasound pulses is frequently applied to destroy bound targeted microbubbles, to quantify accumulated microbubbles or to prepare for successive microbubble injections;...